Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Esperion Therapeutics

Esperion Therapeutics reported $260.32M in Debt for its fiscal quarter ending in March of 2023.

Debt Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 945K
Amgen AMGN:US USD 61.6B 22.65B
Biogen BIIB:US USD 6.28B 1.7M
BioMarin Pharmaceutical BMRN:US USD 1.08B 1.48M
Cytokinetics CYTK:US USD 610.62M 995K
Daiichi Sankyo 4568:JP JPY 143.09B 94M
Eli Lilly LLY:US USD 18.88B 2.64B
Esperion Therapeutics ESPR:US USD 260.32M 417K
Geron GERN:US USD 51.4M 242K
Halozyme Therapeutics HALO:US USD 1.49B 11.72M
Heron Therapeutics HRTX:US USD 149.33M 51K
Intercept Pharmaceuticals ICPT:US USD 333.04M 367K
Ionis Pharmaceuticals IONS:US USD 1.19B 2.36M
Moderna Inc MRNA:US USD 984M 89M
PTC Therapeutics PTCT:US USD 1.35B 3.4M
Puma Biotechnology PBYI:US USD 98.62M 316K
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Sarepta Therapeutics SRPT:US USD 1.23B 310.01M
United Therapeutics UTHR:US USD 800M 0